Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency

NCT02693522 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Hormone Deficiency

Interventions

DRUG: somatropin
DRUG: Eutropin

Sponsor

Daewoong Pharmaceutical Co. LTD.